Why was the Empire Wind vessel cancelled nearly complete?
How will Nvidia's UAE approval impact its stock?
What caused the recent Federal Reserve chair candidate narrowing?
Why is New York Attorney General Letitia James indicted?
How is the government shutdown affecting small businesses?
Why are China and the US escalating port fee charges?
What triggered Tesla's latest safety probe on self-driving cars?
Sanofi AlphaMedix Study Hits Key Milestones In Phase 2 Study
benzinga.com/news/health-care/25/10/48098211/sanofi-alphamedix-milestone-study-for-gep-nets
Sanofi SA (NASDAQ:SNY) on Wednesday released topline data from a phase 2 study evaluating the efficacy and safety of AlphaMedix (212Pb-DOTAMTATE).
The patients had unresectable or metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs), positive somatostatin analog imaging,…
This story appeared on benzinga.com, 2025-10-08 13:04:07.